Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-25-107058
Filing Date
2025-11-05
Accepted
2025-11-05 16:33:23
Documents
15
Period of Report
2025-11-05

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2529850d5_6k.htm 6-K 15271
2 EXHIBIT 1.1 tm2529850d5_ex1-1.htm EX-1.1 269344
3 EXHIBIT 4.1 tm2529850d5_ex4-1.htm EX-4.1 101672
4 EXHIBIT 4.2 tm2529850d5_ex4-2.htm EX-4.2 71952
5 EXHIBIT 4.3 tm2529850d5_ex4-3.htm EX-4.3 74879
6 EXHIBIT 4.4 tm2529850d5_ex4-4.htm EX-4.4 74935
7 EXHIBIT 4.5 tm2529850d5_ex4-5.htm EX-4.5 74811
8 EXHIBIT 4.6 tm2529850d5_ex4-6.htm EX-4.6 75048
9 EXHIBIT 4.7 tm2529850d5_ex4-7.htm EX-4.7 85617
10 EXHIBIT 4.8 tm2529850d5_ex4-8.htm EX-4.8 33230
11 EXHIBIT 5.1 tm2529850d5_ex5-1.htm EX-5.1 16702
12 EXHIBIT 5.2 tm2529850d5_ex5-2.htm EX-5.2 49330
13 GRAPHIC tm2529850d5_ex1-1sp01img001.jpg GRAPHIC 5524
14 GRAPHIC tm2529850d5_ex4-1img001.jpg GRAPHIC 5484
15 GRAPHIC tm2529850d5_ex5-2img001.jpg GRAPHIC 8535
  Complete submission text file 0001104659-25-107058.txt   971214
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filer) CIK: 0001114448 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-15024 | Film No.: 251454615
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)